インフレーション抑制法（Inflation Reduction Act）は医薬品開発の意思決定に影響を及ぼすか
The short answer is yes. In fact, passage of the Inflation Reduction Act (H.R. 5376)…
Certara2023年1月27日
How Drug Developers can Navigate the Inflation Reduction Act of 2022
Learn how the IRA will impact how new drugs are marketed and why negotiating pricing…
Certara2023年1月27日
Exceling at Accelerating in Rare Disease Drug Development
By: Rajesh Krishna, PhD, FAAPS and Steve Sibley According to the National Institutes of Health,…
Certara2023年1月26日
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
An novel single dose regimen of tremelimumab combined with durvalumab could be a way to…
Certara2023年1月26日
Tips & Tricks for Streamlining Non-compartmental Pharmacokinetic Analysis
These Phoenix tips and tricks will help you exclude Lambda Z, name partial areas, and…
Certara2023年1月20日
D360 as your organization’s extendable and central data engine
D360 is an industry-leading scientific data informatics platform providing a flexible, scalable, and customizable enterprise…
Certara2023年1月20日
Physiologically-Based Pharmacokinetic Modeling & Simulation to Support Asciminib NDA Submission & Inform Drug Product Label
Physiologically based pharmacokinetic (PBPK) modeling and simulation has become an established approach to assess drug-drug…
Certara2023年1月13日
Certara Awarded NIH Contract for Toxicology Consulting Support
Certara toxicology experts to support NIH’s BPN and HEAL drug development programs for nervous system…
Certara2023年1月10日
